Ming  Yan net worth and biography

Ming Yan Biography and Net Worth

Dr. Yan is a co-founder of Cytek Biosciences with over 25 years of R&D experience in leadership and innovation. As CTO of Cytek, Ming leads the development team (including hardware, software, reagents, and applications), and with the team, drives the advancement of the Cytek Platform.

Prior to Cytek, Ming worked in the biomedical instruments industry and integrated photonics at AT&T Bell laboratories, Livermore national laboratories, Neophotonics and BD Biosciences. Ming is one of the thought-leaders in flow cytometry instrumentation and standardization. He received his Ph.D in Electrical Engineering and MS in Physics from City University of New York, BS in Physics from Fudan University.

Dr. Yan has published over 40 research papers relating to laser spectroscopy and cell analysis in top peer-reviewed journals. He has over a dozen patents and patent pending applications for his innovations.

What is Ming Yan's net worth?

The estimated net worth of Ming Yan is at least $30.60 million as of April 19th, 2024. Dr. Yan owns 5,988,502 shares of Cytek Biosciences stock worth more than $30,601,245 as of November 2nd. This net worth approximation does not reflect any other investments that Dr. Yan may own. Additionally, Dr. Yan receives an annual salary of $616,260.00 as CTO at Cytek Biosciences. Learn More about Ming Yan's net worth.

How old is Ming Yan?

Dr. Yan is currently 61 years old. There are 6 older executives and no younger executives at Cytek Biosciences. The oldest executive at Cytek Biosciences is Mr. William D. McCombe, Chief Financial Officer, who is 66 years old. Learn More on Ming Yan's age.

What is Ming Yan's salary?

As the CTO of Cytek Biosciences, Inc., Dr. Yan earns $616,260.00 per year. The highest earning executive at Cytek Biosciences is Dr. Wenbin Jiang Ph.D., President, CEO & Chairman of the Board, who commands a salary of $964,210.00 per year. Learn More on Ming Yan's salary.

How do I contact Ming Yan?

The corporate mailing address for Dr. Yan and other Cytek Biosciences executives is , , . Cytek Biosciences can also be reached via phone at 877-922-9835 and via email at [email protected]. Learn More on Ming Yan's contact information.

Has Ming Yan been buying or selling shares of Cytek Biosciences?

Ming Yan has not been actively trading shares of Cytek Biosciences within the last three months. Most recently, Ming Yan sold 20,000 shares of the business's stock in a transaction on Friday, April 19th. The shares were sold at an average price of $5.87, for a transaction totalling $117,400.00. Following the completion of the sale, the chief technology officer now directly owns 5,988,502 shares of the company's stock, valued at $35,152,506.74. Learn More on Ming Yan's trading history.

Who are Cytek Biosciences' active insiders?

Cytek Biosciences' insider roster includes Wenbin Jiang (CEO), and Ming Yan (CTO). Learn More on Cytek Biosciences' active insiders.

Are insiders buying or selling shares of Cytek Biosciences?

During the last year, insiders at the sold shares 8 times. They sold a total of 107,900 shares worth more than $711,420.00. The most recent insider tranaction occured on April, 19th when CTO Ming Yan sold 20,000 shares worth more than $117,400.00. Insiders at Cytek Biosciences own 9.6% of the company. Learn More about insider trades at Cytek Biosciences.

Information on this page was last updated on 4/19/2024.

Ming Yan Insider Trading History at Cytek Biosciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/19/2024Sell20,000$5.87$117,400.005,988,502View SEC Filing Icon  
4/9/2024Sell1,900$7.00$13,300.006,008,502View SEC Filing Icon  
3/18/2024Sell20,000$6.77$135,400.006,030,402View SEC Filing Icon  
12/19/2023Sell20,000$9.43$188,600.006,042,103View SEC Filing Icon  
11/20/2023Sell20,000$6.03$120,600.007,762,103View SEC Filing Icon  
10/19/2023Sell20,000$4.80$96,000.007,775,962View SEC Filing Icon  
9/19/2023Sell20,000$6.49$129,800.007,795,962View SEC Filing Icon  
8/21/2023Sell20,000$8.07$161,400.007,815,962View SEC Filing Icon  
7/19/2023Sell20,000$8.76$175,200.007,830,258View SEC Filing Icon  
6/20/2023Sell20,000$8.18$163,600.007,850,258View SEC Filing Icon  
5/19/2023Sell20,000$7.19$143,800.007,870,258View SEC Filing Icon  
4/19/2023Sell20,000$9.71$194,200.007,886,053View SEC Filing Icon  
3/20/2023Sell20,000$9.29$185,800.007,906,053View SEC Filing Icon  
2/21/2023Sell20,000$10.94$218,800.007,926,053View SEC Filing Icon  
2/8/2023Sell897$13.53$12,136.417,944,844View SEC Filing Icon  
2/3/2023Sell1,092$13.50$14,742.007,945,741View SEC Filing Icon  
1/19/2023Sell20,000$11.03$220,600.007,946,833View SEC Filing Icon  
12/19/2022Sell20,000$10.38$207,600.007,966,833View SEC Filing Icon  
11/21/2022Sell20,000$14.66$293,200.007,986,833View SEC Filing Icon  
10/19/2022Sell20,000$14.42$288,400.008,005,624View SEC Filing Icon  
9/19/2022Sell20,000$12.42$248,400.008,025,624View SEC Filing Icon  
8/19/2022Sell20,000$13.62$272,400.008,045,624View SEC Filing Icon  
7/19/2022Sell20,000$11.83$236,600.008,064,415View SEC Filing Icon  
6/21/2022Sell20,000$10.06$201,200.008,084,415View SEC Filing Icon  
5/19/2022Sell20,000$9.92$198,400.008,104,415View SEC Filing Icon  
4/19/2022Sell20,000$10.34$206,800.008,122,803View SEC Filing Icon  
3/21/2022Sell20,000$11.64$232,800.00View SEC Filing Icon  
2/22/2022Sell20,000$13.44$268,800.00View SEC Filing Icon  
2/10/2022Sell20,000$15.11$302,200.00View SEC Filing Icon  
See Full Table

Ming Yan Buying and Selling Activity at Cytek Biosciences

This chart shows Ming Yan's buying and selling at Cytek Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cytek Biosciences Company Overview

Cytek Biosciences logo
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Read More

Today's Range

Now: $5.11
Low: $4.95
High: $5.23

50 Day Range

MA: $5.21
Low: $4.69
High: $5.74

2 Week Range

Now: $5.11
Low: $3.80
High: $9.87

Volume

824,291 shs

Average Volume

669,180 shs

Market Capitalization

$672.02 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.3